PA
SPRY icon

Profund Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Profund Advisors’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$420K Buy
52,328
+9,520
+22% +$91.2K 0.02% 604
2025
Q4 		$499K Buy
42,808
+16,478
+63% +$160K 0.02% 566
2025
Q3 		$265K Buy
26,330
+9,242
+54% +$133K 0.01% 809
2025
Q2 		$298K Buy
17,088
+1,264
+8% +$18.2K 0.01% 695
2025
Q1 		$199K Sell
15,824
-11,046
-41% -$133K 0.01% 908
2024
Q4 		$283K Buy
26,870
+10,467
+64% +$147K 0.01% 796
2024
Q3 		$238K Buy
16,403
+274
+2% +$3.26K 0.01% 955
2024
Q2 		$137K Sell
16,129
-1,303
-7% -$11.6K 0.01% 1025
2024
Q1 		$178K Buy
+17,432
New +$130K 0.01% 1090

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return